|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
DICLOFENAC |
S01BC03 |
SI
|
Not authorised
|
30-05-2025 |
5363-I-826/03 |
01-01-2004 |
VALID
|
|
INTERFERON BETA-1A |
L03AB07 |
SI
|
I
|
30-05-2025 |
5363-I-829/03 |
23-12-2003 |
VALID
|
|
VARIOUS |
R02AA20 |
SI
|
Not subject to prescription
|
30-05-2025 |
5363-I-85/04 |
10-02-2004 |
VALID
|
|
HYPERTONIC SOLUTIONS |
B05DB |
SI
|
POM
|
30-05-2025 |
5363-I-86/05 |
13-03-2007 |
VALID
|
|
NORGESTREL AND ETHINYLESTRADIOL |
G03AA06 |
SI
|
Not authorised
|
30-05-2025 |
5363-I-88/04 |
16-02-2004 |
VALID
|
|
DEXAMETHASONE |
H02AB02 |
SI
|
I
|
30-05-2025 |
5363-I-89/02 |
27-02-2002 |
VALID
|
|
FIBRINOLYSIN AND DESOXYRIBONUCLEASE |
B06AA02 |
SI
|
Not authorised
|
30-05-2025 |
5363-I-89/03 |
25-02-2003 |
VALID
|
|
ROSUVASTATIN |
C10AA07 |
SI
|
POM
|
30-05-2025 |
5363-I-9/04 |
06-01-2004 |
VALID
|
|
MULTIENZYMES (LIPASE, PROTEASE ETC.) |
A09AA02 |
SI
|
POM
|
30-05-2025 |
5363-I-940/06 |
|
VALID
|
|
ACICLOVIR |
D06BB03 |
SI
|
Not authorised
|
30-05-2025 |
5363-I-969/05 |
17-01-2007 |
VALID
|
|
GABAPENTIN |
N02BF01 |
SI
|
POM
|
30-05-2025 |
5363-I-983/05 |
13-02-2007 |
VALID
|
|
ATORVASTATIN |
C10AA05 |
SI
|
POM
|
30-05-2025 |
5363-I-987/05 |
02-04-2007 |
VALID
|
|
LISINOPRIL AND DIURETICS |
C09BA03 |
SI
|
POM
|
30-05-2025 |
5363-I-99/03 |
26-02-2003 |
VALID
|
|
MORPHINE |
N02AA01 |
SI
|
I
|
30-05-2025 |
5363-I-99/05 |
04-05-2005 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B02BD16 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
MIRVETUXIMAB SORAVTANSINE |
L01FX26 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005036 |
14-11-2024 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
TIRATRICOL |
H03AA04 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005220 |
12-02-2025 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
TOFERSEN |
N07XX22 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005493 |
29-05-2024 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
MITAPIVAT |
B06AX04 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
SOTATERCEPT |
C02KC06 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005647 |
22-08-2024 |
VALID
|
|
VAMOROLONE |
H02AB18 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
CATUMAXOMAB |
L01FX03 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005697 |
10-02-2025 |
VALID
|
|
BEVACIZUMAB |
S01LA08 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005723 |
27-05-2024 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
SPARSENTAN |
C09XX01 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
MARIBAVIR |
J05AX10 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
SI
|
Not authorised
|
30-05-2025 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
SI
|
POM
|
30-05-2025 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
